September 3, 2025 · Form 4 insider transaction
Megna Michael R bought 11,000 shares of Kiniksa Pharmaceuticals Ltd. at $17.92 per share, a transaction worth $197.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024.